Compare UBC Medical Indonesia Tbk. (LABS) vs Waran Seri I Pyridam Farma Tbk. (PYFA-W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Waran Seri I Pyridam Farma Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp161 (market cap 635.95B), while Waran Seri I Pyridam Farma Tbk. trades at Rp62 (market cap 11.05B). The key difference: UBC Medical Indonesia Tbk. is far larger — about 57.6× Waran Seri I Pyridam Farma Tbk.'s market cap. Which is the better fit depends on your goals.
| LABS | PYFA-W | |
|---|---|---|
Market Cap | 635.95B | 11.05B |
Indicative Equilibrium Price | 163 | — |
Indicative Equilibrium Volume | 16 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Waran Seri I Pyridam Farma Tbk.
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA-W →
